Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

[Investigation of allergic reactions to platinum salts].

Touraine F, Sainte Laudy J, Boumediene A, Ndikumwenayo F, Decroisette C, Melloni B, Vergnenegre A, Bonnaud F.

Rev Mal Respir. 2006 Nov;23(5 Pt 1):458-62. French.

PMID:
17314746
2.

Alimta (pemetrexed disodium): a multitargeted antifolate for the treatment of mesothelioma.

Green MR.

Lung Cancer. 2002 Nov;38 Suppl 2:S55-7. Review.

PMID:
12431831
3.

Pemetrexed-cisplatin combination in mesothelioma.

Reck M, Gatzemeier U.

Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. Review.

PMID:
15877521
4.

Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.

Suwanrusme H, Meyer ML, Green MR.

Clin Lung Cancer. 2004 Apr;5 Suppl 2:S56-60. Review.

PMID:
15117426
5.

[Update of pemetrexed in thoracic oncology].

Brechot JM, Morère JF.

Bull Cancer. 2007;94 Spec No Actualites:S139-41. Review. French.

PMID:
17845984
6.

[Chemotherapy of malignant pleural mesothelioma: have we made any progress?].

Reck M, Heigener DF, Gatzemeier U.

Zentralbl Chir. 2008 Jun;133(3):238-42. doi: 10.1055/s-2008-1004809. Review. German.

PMID:
18563688
7.
8.

Pemetrexed in first-line treatment of non-small cell lung cancer.

Esteban E, Casillas M, Cassinello A.

Cancer Treat Rev. 2009 Jun;35(4):364-73. doi: 10.1016/j.ctrv.2009.02.002. Epub 2009 Mar 6. Review.

PMID:
19269106
9.

Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.

Ferraldeschi R, Thatcher N, Lorigan P.

Expert Rev Anticancer Ther. 2007 May;7(5):635-40. Review.

PMID:
17492928
10.

[A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy].

Igarashi K, Hayashi M, Sato M, Aiba T, Yoneyama O, Waguri N, Furukawa K, Sugimura K, Shibuya H.

Nihon Shokakibyo Gakkai Zasshi. 2012 Mar;109(3):451-9. Review. Japanese.

PMID:
22398911
11.

Malignant peritoneal mesothelioma (MPM) who responded to rechallenge with cisplatin and pemetrexed with current literature review.

Gilani SN, Gridley R, Searle G, Jegannathen A.

BMJ Case Rep. 2013 Jan 3;2013. pii: bcr2012007786. doi: 10.1136/bcr-2012-007786. Review.

12.

Can pemetrexed help in malignant mesothelioma?

[No authors listed]

Drug Ther Bull. 2006 Oct;44(10):77-80. Review.

PMID:
17067119
13.

[Pemetrexed: from preclinic to clinic].

Lansiaux A, Lokiec F.

Bull Cancer. 2007;94 Spec No Actualites:S134-8. Review. French.

PMID:
17845983
14.

The potential role of pemetrexed in gastrointestinal cancer.

Meriggi F, Di Biasi B, Caliolo C, Zaniboni A.

Chemotherapy. 2008;54(1):1-8. Epub 2007 Dec 7. Review.

PMID:
18063861
15.

Current options for systemic therapy in mesothelioma.

Jackman DM.

Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):154-8. doi: 10.1053/j.semtcvs.2009.06.010. Review.

PMID:
19822287
16.

Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin.

Shukunami K, Kurokawa T, Kubo M, Kaneshima M, Kamitani N, Kotsuji F.

Tumori. 1999 Jul-Aug;85(4):297-8. Review.

PMID:
10587037
17.

[Pemetrexed development in oncology].

Chaigneau L, Villanueva C, Thierry-Vuillemin A, Legat-Fagnoni C, N'Guyen T, Maurina T, Lorgis V, Pivot X.

Bull Cancer. 2007;94 Spec No Actualites:S142-8. Review. French.

PMID:
17845985
18.

[New approaches for mesothelioma].

Morère JF.

Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S57-4S60. Review. French. No abstract available.

PMID:
15687997
19.

[About side effects of platinum drugs].

Waszkiewicz K.

Postepy Hig Med Dosw. 2001;55(3):387-406. Review. Polish.

PMID:
11505639
20.

Carboplatin hypersensitivity.

Sliesoraitis S, Chikhale PJ.

Int J Gynecol Cancer. 2005 Jan-Feb;15(1):13-8. Review.

PMID:
15670291

Supplemental Content

Support Center